WallStreetZenWallStreetZen

NASDAQ: MIRA
Mira Pharmaceuticals Inc Earnings & Revenue

MIRA earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$12.0M
Current Profit Margin
0%

MIRA Return on Equity

Current Company
-402.9%
Current Industry
-63.5%
Current Market
188.7%
MIRA's Return on Equity (-402.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when MIRA announces earnings.

MIRA Return on Assets

Current Company
-263.7%
Current Industry
2.9%
MIRA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

MIRA Return on Capital Employed

Current Company
-194.91%
Current Industry
19.5%

MIRA vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
MIRA$0.00-$8.53M-$11.98MN/AN/A
NNVC$0.00-$8.55M-$9.36MN/AN/A
TRAW$226.00k-$18.93M-$18.95M-28.72%N/A
KPRX$0.00-$12.35M-$13.04M-100.00%N/A
XTLB$0.00-$1.35M-$1.35MN/AN/A

Mira Pharmaceuticals Earnings & Revenue FAQ

What were MIRA's earnings last quarter?

On Invalid Date, Mira Pharmaceuticals (NASDAQ: MIRA) reported Q4 2023 earnings per share (EPS) of -$0.19, up 733.33% year over year. Total Mira Pharmaceuticals earnings for the quarter were -$5.79 million. In the same quarter last year, Mira Pharmaceuticals's earnings per share (EPS) was $0.03.

If you're new to stock investing, here's how to buy Mira Pharmaceuticals stock.

What was MIRA's earnings growth in the past year?

As of Q2 2024, Mira Pharmaceuticals's earnings has grown year over year. Mira Pharmaceuticals's earnings in the past year totalled -$11.98 million.

What was MIRA's revenue last quarter?

On Invalid Date, Mira Pharmaceuticals (NASDAQ: MIRA) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Mira Pharmaceuticals's revenue was $0.00.

What was MIRA's revenue growth in the past year?

As of Q2 2024, Mira Pharmaceuticals's revenue has grown null year over year. Mira Pharmaceuticals's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.